Adiponectin in patients with obstructive sleep apnea syndrome: Course and physiological relevance

Respiration

Volumn 71, Issue 6, 2004, Pages 580-586

  Harsch, I A ^a   Wallaschofski, H ^a   Koebnick, C ^b   Pour Schahin, S ^a   Hahn, E G ^a   Ficker, J H ^a   Lohmann, T ^c  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Adiponectin; Continuous positive airway pressure therapy; Insulin sensitivity; Obstructive sleep apnea syndrome; P Selectin; RANTES

Indexed keywords

ADIPONECTIN; CYTOKINE; INSULIN; PADGEM PROTEIN; RANTES;

ADULT; AGED; APNEA; ARTICLE; BODY FAT; BODY MASS; BREATHING DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; HUMAN; HYPOPNEA; INSULIN SENSITIVITY; MALE; OBESITY; PHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; T LYMPHOCYTE; THROMBOCYTE ACTIVATION;

AGED; BODY COMPOSITION; BODY WEIGHT; COMORBIDITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE;

EID: 11844258841     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081758     Document Type: Article

References (24)

1. Trzebski A, Smietanowski M, Zebrowski J: Repetitive apneas reduce nonlinear dynamical complexity of the human cardiovascular control system. J Physiol Pharmacol 2001;52:3-19.
2. Stoohs RA, Facchini F, Guilleminault C: Insulin resistance and sleep disordered breathing in healthy humans. Am J Respir Crit Care Med 1996;154:170-174.
3. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946.
4. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA: Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935.
5. Staiger H, Tschritter O, Machann J, Thamer C, Fritsche A, Maerker E, Schick F, Haring HU, Stumvoll M: Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res 2003;11:368-372.
6. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF: Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;18:226-228.
7. Harsch IA, Pour Schahin S, Radespiel-Tröger M, Weintz O, Jahreiß H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC, Ficker JH: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-162.
8. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F; Centers for Disease Control and Prevention; American Heart Association: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
9. Nomura S, Shouzou A, Omoto S, Nishikawa M, Fukuhara S: Significance of chemokines and activated platelets in patients with diabetes. Clin Exp Immunol 2000;121:437-443.
10. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD: Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 2000;97:13835-13840.
11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
12. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 1997;20:1183-1197.
13. Penzel T, Hajak G, Hoffmann RM, et al: Empfehlungen zur Durchführung und Auswertung polygrafischer Ableitungen im diagnostischen Schlaflabor. EEG EMG 1993;24:65-70.
14. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
15. Indications and standards for use of nasal continuous airway pressure (CPAP) in sleep apnea syndromes. American Thoracic Society. Official statement adopted March 1944. Am J Respir Crit Care Med 1994;150:1738-1745.
16. Rechtschaffen A, Kahles A: A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, Public Health Service, US Government Printing Office, 1968.
17. EEG arousals: Scoring rules and examples: A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173-184.
18. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y: Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126-1133.
19. Shand BI, Scott RS, Elder PA, George PM: Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 2003;5:349-353.
20. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingericg RL, Meneilly GS, Egan JM, Elahi D: Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care 2003;26:2383-2388.
21. Chasens ER, Weaver TE, Umlauf MG: Insulin resistance and obstructive sleep apnea: Is increased sympathetic stimulation the link ? Biol Res Nurs 2003;5:87-96.
22. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M: Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-1134.
23. Imagawa S, Yamaguchi Y, Ogawa K, Obara N, Suzuki N, Yamamoto M, Nagasawa T: Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration 2004;71:24-29.
24. Harsch IA, Pour Schahin S, Brückner K, Radespiel-Tröger M, Fuchs FS, Hahn EG, Konturek PC, Lohmann T, Ficker JH: The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration 2004;71:252-259.